Stock & Company Details
BriaCell Therapeutics Corp $BCTX
Price:
N/A
N/A
8.7M
$32M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.22
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BCTX technical indicators
Latest BriaCell Therapeutics Corp (BCTX) indicator readings as of 2026-08-28.
BCTX's 14-day RSI is 52.2, in neutral territory. At $3.73 it is trading 24.7% below its 200-day moving average of $4.95, and above its 50-day average of $3.52. Price sits in the middle of its Bollinger Bands ($3.14 to $4.06). ADX reads 13.0, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Finance Bot
Ask your questions
Start by typing a question below.
